Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables... Show more
On September 05, 2025, the Stochastic Oscillator for RPID moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 47 instances where the indicator left the oversold zone. In of the 47 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RPID's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on September 05, 2025. You may want to consider a long position or call options on RPID as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for RPID just turned positive on September 05, 2025. Looking at past instances where RPID's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RPID advanced for three days, in of 180 cases, the price rose further within the following month. The odds of a continued upward trend are .
RPID may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
RPID moved below its 50-day moving average on July 31, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RPID crossed bearishly below the 50-day moving average on August 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPID declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for RPID entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.205) is normal, around the industry mean (60.043). P/E Ratio (0.000) is within average values for comparable stocks, (38.046). RPID's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.677). RPID has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (3.953) is also within normal values, averaging (80.366).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RPID’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RPID’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor tells us that RPID and SDMHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RPID and SDMHF's prices will move in lockstep.
Ticker / NAME | Correlation To RPID | 1D Price Change % | ||
---|---|---|---|---|
RPID | 100% | +11.48% | ||
SDMHF - RPID | 30% Poorly correlated | +0.18% | ||
NNOX - RPID | 29% Poorly correlated | -0.81% | ||
GKOS - RPID | 29% Poorly correlated | +4.22% | ||
ISRG - RPID | 28% Poorly correlated | +2.71% | ||
HYPR - RPID | 27% Poorly correlated | +4.46% | ||
More |
Ticker / NAME | Correlation To RPID | 1D Price Change % |
---|---|---|
RPID | 100% | +11.48% |
Medical/Nursing Services industry (226 stocks) | 26% Poorly correlated | +0.46% |
Health Services industry (439 stocks) | 21% Poorly correlated | -0.02% |